FMR CORP 13D and 13G filings for Royalty Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:30 am Sale |
2024-12-31 | 13G | Royalty Pharma plc RPRX |
FMR CORP | 26,309,327 5.900% |
-5,274,599 (-16.70%) |
Filing |
| 2024-02-09 09:49 am Sale |
2024-02-08 | 13G | Royalty Pharma plc RPRX |
FMR CORP | 31,583,926 7.099% |
-12,526,439 (-28.40%) |
Filing |
| 2023-02-09 12:31 pm Purchase |
2023-02-09 | 13G | Royalty Pharma plc RPRX |
FMR CORP | 44,110,365 9.999% |
22,030,570 (+99.78%) |
Filing |
| 2022-02-09 10:24 am Sale |
2022-02-08 | 13G | Royalty Pharma plc RPRX |
FMR CORP | 22,079,795 5.140% |
-2,862,750 (-11.48%) |
Filing |
| 2021-02-08 10:31 am Purchase |
2021-02-05 | 13G | Royalty Pharma plc RPRX |
FMR CORP | 24,942,545 6.426% |
24,942,545 (New Position) |
Filing |